Beijing Huashen Pharmaceutical Co., Ltd.
Beijing Huashen Pharmaceutical Co., Ltd.
Chairman: Cao Hongxin General Manager: Hao Yucheng Registered capital: 30 million Registered address: No. 110, Dongxiaokou Zhongtan, Changping District, Beijing Established: 1995
Representative products: Astragali Vermiculite and Lowering Glycemic Tablets, Shuanghu Liver Clearing Granules, Nourishing Yin and Shengxue Combination, Yilun Lung Clearing and Hepatization Granules, etc. Beijing Huashen Pharmaceutical Co. Ltd. was established in 1995, is the China Academy of Traditional Chinese Medicine and the Hong Kong China Resources Group *** with the investment in the construction of modern pharmaceutical enterprises, is the largest joint venture project of the China Academy of Traditional Chinese Medicine so far, is also the first investment in the field of traditional Chinese medicine by the Hong Kong China Resources Group, an important project.
The company is headed by Mr. Cao Hongxin, President of China Academy of Traditional Chinese Medicine (TCM), and Mr. Hao Yuqing, General Manager. The company is located in Changping Park, Zhongguancun Science and Technology Park, Beijing, and is a high-tech enterprise recognized by the Beijing Science and Technology Commission. It covers an area of 25,000 square meters with a factory building of 8,500 square meters. From the time of establishment, the company aims at the leading position in China and pursues modernization, high technology and demonstration. The factory has a beautiful environment, reasonable layout, excellent equipment, facilities and equipment, and advanced technology. The company now has six production lines for granules, combinations, tablets, capsules, coated agents and sprays, all of which have passed GMP certification.
The company's marketing center is located in the courtyard of China Academy of Traditional Chinese Medicine. The marketing center focuses on a group of talents with doctoral, master's and bachelor's degrees, with modern thinking and innovation ability, opening up a new marketing model, building a sales network covering all over the country, has now established business contacts with Hong Kong, Taiwan, Malaysia, South Korea and other regions and countries, and is gradually expanding to Europe and the United States to extend the market.
The company is backed up by the strong economic strength of Hong Kong China Resources Group, giving full play to the scientific research advantages of China Academy of Traditional Chinese Medicine in the field of traditional Chinese medicine research, through the application of modern high-tech, the implementation of national high-tech industrial development projects. Existing products such as "Shuanghu Liver Pellet" and "Nourishing Yin and Blood Combination" are at the leading level in China, which have been successively appraised as the National Torch Plan Project and the Key Achievement Promotion Project of the Chinese Medicine Administration, and have won the Science and Technology Progress Prize of Beijing Municipality, and have achieved a greater success in market promotion. The products have also gained greater success in market promotion. At present, a number of new Chinese medicines with high technological content, accurate therapeutic effect and convenient consumption are being researched, developed and declared, and will be put on the market soon.
The company is facing the new century with a brand-new outlook, following the business philosophy of "maximizing the value of shareholders and employees", adhering to the entrepreneurial spirit of "honesty, dedication, pragmatism, and innovation", and in accordance with the direction of large-scale, high-technology, and high efficiency, it aspires to develop into one of the leading companies in China. In accordance with the direction of large-scale, high-tech, high-efficiency, we aspire to develop into a first-class domestic and internationally renowned modern pharmaceutical enterprise group.
Sincerely hope to cooperate with colleagues in the pharmaceutical industry, **** create brilliant!
Training Center
The Training Center of China Academy of Traditional Chinese Medicine (CATCM) was established in 1994, which is a training institution directly under China Academy of Traditional Chinese Medicine (CATCM). After more than a decade of construction, China Academy of Traditional Chinese Medicine Training Center has become an important continuing education and vocational skills training base of the China Academy of Traditional Chinese Medicine, the center aims to make full use of the talent and technical advantages of the China Academy of Traditional Chinese Medicine for domestic and foreign in-service Chinese medicine practitioners, Chinese herbalists, acupuncturists, massage therapists, cosmetology, and hobbyists in traditional Chinese medicine to provide an opportunity for learning, advanced study, exchange, and to help them to improve the medical It also serves as an academic window for the Chinese Academy of Traditional Chinese Medicine to publicize its scientific research achievements and old, middle-aged and young experts.
Since its establishment, the center has hired senior experts from the China Academy of Chinese Medicine to form a teaching team, relying on the China Academy of Chinese Medicine to provide high-quality services and quality education and training environment for students at home and abroad with excellent teaching quality, formal teaching management and careful and responsible organization of the reception, which has been highly praised and established a good image in the industry.
The training center enrolls students all year round, organizes various kinds of junior, middle and senior classes, and also organizes various kinds of ad hoc classes according to the specific requirements of the learners, in addition, the training center also undertakes the training projects before the Chinese medicine level examination and international acupuncture, massage level examination, and the pre-test training of various vocational skills qualification examinations. At the same time also opened a variety of correspondence, network distance learning training classes, for students at home and abroad to provide more convenient, fast teaching services, learning, further training will be issued after the end of the certificate of completion of the Chinese and English.
Chinese Medicine Science and Technology Cooperation Center
(Beijing Zhongyan International Pharmaceutical Company)
Chinese Medicine Science and Technology Cooperation Center of China Academy of Traditional Chinese Medicine (CAMSTC) is a unit under China Academy of Traditional Chinese Medicine (CAMSTC) with the qualification of an independent legal person, established in 1993, with the office located at No. 16, Nanxiaojie, Dongzhimennei, Beijing, and Dr. YAN Liang, Director of the Center.
The center's business includes transferring new products and technologies of the Academy of Chinese Medicine to enterprises producing Chinese medicine and health care products; jointly developing new products with enterprises, acting as an agent for the approval of new products, and providing technical consultancy and services for the research and development of products as well as for the production and improvement of the products; providing new or characteristic Chinese medicine diagnostic and treatment technologies, medical management consultancy, and characteristic Chinese medicine health care or technologies; and providing services for the development of Chinese medicine talents from China and for the development of Chinese medicine organizations from abroad. It also provides two-way services for the development of domestic Chinese medicine talents going abroad and the introduction of Chinese medicine talents from China by foreign Chinese medicine institutions; organizes academic exchanges of domestic and international Chinese medicine; conducts transactions of practical or applied technologies of Chinese medicine; organizes or participates in the organization of academic seminars of domestic and international Chinese medicine, exhibitions of products and technologies, and carries out on-line transactions and other forms of technological intermediary services.
Through playing the role of "bridge" and "platform", it promotes the transformation of scientific research results in Chinese medicine and the internationalization of Chinese medicine, and establishes cooperative relationships with relevant foreign institutions in the fields of scientific research, medical treatment, education and industry of Chinese medicine. Expanding the international influence of the Academy of Chinese Medicine, expanding the international development of Chinese medicine space to promote the development of the cause of Chinese medicine.
After more than a decade of tireless efforts, the Center has carried out fruitful work around the above business, and established a wide range of business channels and a good reputation at home and abroad. We will continue to move forward positively and steadily towards the set goals!
The Center has set up the Medicine and Health Products Development Center. With the aim of promoting the standardization, industrialization and internationalization of China's traditional Chinese medicine industry, the Pharmaceutical and Healthcare Products Development Center provides R&D declaration, technical supervision, technology transfer and overseas promotion services for enterprises of traditional Chinese medicine and healthcare products.
The R&D Center has R&D personnel who are well versed in pharmacology and medicine and familiar with policies and regulations, and also employs academic authorities and review experts in the hospital to guard the research projects, so as to minimize the risk and cost of new product development, shorten the development cycle of the new products, and promote the industrialization of the achievements of traditional Chinese medicine and health care science and technology as soon as possible.
Since its establishment, the Center has helped many enterprises to complete dozens of new drugs and health food R & D declarations, and promoted a number of new drugs and health food to the international market. The center will continue to provide high quality and comprehensive technical services for enterprises, welcome enterprises to negotiate with us for cooperation.
China Research International Pharmaceutical Company
Beijing China Research International Company (CRIC) was founded in 1984 (formerly known as China Academy of Traditional Chinese Medicine Pharmaceutical Technology Development Company), which is a wholly-owned, nationally-owned enterprise sponsored by the China Academy of Traditional Chinese Medicine (CATA), and is the first company with import and export rights in the system of the State Administration of Traditional Chinese Medicine (SATCM).
The company aims at the internationalization of Chinese medicine, with international and domestic marketing of Chinese medicine-related products as its main business. The company operates the export business of the technologies and scientific and technological products developed by the China Academy of Traditional Chinese Medicine and the enterprises directly under it, as well as the import business of the technologies, raw and auxiliary materials, machinery and equipment, instruments and spare parts required for production. The company's domestic business scope includes: technology development, transfer, training, consulting services and new product development, production and sales of pharmaceuticals, medical devices, health care products, hygiene products and so on. In the past ten years, the company has established business relations with more than forty countries and regions in five continents.
As a backbone enterprise directly under the China Academy of Traditional Chinese Medicine (CATCM), "high efficiency, safety, new type and high quality" are the screening criteria for our products. Relying on the scientific and technological advantages of CATCM, the company adheres to the spirit of credibility first, quality first and customer first. We will adhere to the consistent principles, dedicated to serving the community, and welcome cooperation.
Chinese Academy of Traditional Chinese Medicine Experimental Pharmaceutical Factory
Basic information
Corporate representative: Li Rongsheng Registered capital: 4,260,000 yuan
Registered address: No. 16, South Xiaojie Street, Dongzhimen, Dongcheng District, Beijing
Establishment time: 1958 Representative new products: Zheng Chaihu Drinking Granules, Xinqingning Tablets, Anti-Senitivity Granules, Clearing the Throat and Pharynx Granules, Chuanbei loquat granules, brain rejuvenation capsule, rest wound music tincture, pig ling polysaccharide injection.
Introduction of enterprise development
Chinese Academy of Traditional Chinese Medicine Experimental Pharmaceutical Factory was established in 1958, officially listed as the Experimental Pharmaceutical Factory of the Institute of Traditional Chinese Medicine of the Chinese Academy of Traditional Chinese Medicine in 1984, and renamed as the Experimental Pharmaceutical Factory of the Chinese Academy of Traditional Chinese Medicine in 1991, which is located in the yard of the Chinese Academy of Traditional Chinese Medicine, and is a nationally-owned enterprise under the Chinese Academy of Traditional Chinese Medicine and a pharmaceutical enterprise with a certain scale, integrating production and scientific research. It is a nationally owned enterprise under the China Academy of Traditional Chinese Medicine, and is a pharmaceutical enterprise with a certain scale of production and scientific research.
Chinese Academy of Traditional Chinese Medicine Experimental Pharmaceutical Factory has eight varieties of granules, tablets, tinctures, capsules and other products, including granules, tablets, tinctures, capsules, etc., which have obtained the GMP certification.
The Experimental Pharmaceutical Factory of China Academy of Traditional Chinese Medicine has distributed marketing outlets all over the country with a certain scale, in order to improve its marketing system and further expand the market share of its products, it is proposed to spend three years to establish a nationwide marketing network. After the completion of the project, it can promote the sales of the pharmaceutical factory to increase year by year.
Cheng Chaihu Drinking Granules and Xinqingning Tablets are currently the main varieties of the Experimental Pharmaceutical Factory of the China Academy of Traditional Chinese Medicine, which have been designated as essential medicines for traditional Chinese medicine hospitals by the State Administration of Traditional Chinese Medicine and the State Drug Administration. They are in the mature stage of their life course, and the products sell well all over the country (especially in Beijing). The new variety of acute cough stop, is the China Academy of Chinese Medicine Experimental Pharmaceutical Factory newly developed for external cough efficient treatment of prescription drugs, easy to take, safe and inexpensive, non-toxic side effects, is a purely natural Chinese medicine preparations, has a good market outlook. If the trial sale of the right way, you can increase investment year by year. China Academy of Chinese Medicine Experimental Pharmaceutical Plant anti-tumor drugs are currently in the development stage. According to the length of the research cycle, it cooperates with some short, flat and fast projects to create near-term benefits. When putting new products on the market, strengthen market research, increase investment in product promotion, fully utilize its own sales network and China Academy of Traditional Chinese Medicine, a huge intangible asset, to create a brand effect, so that the new drug can be fully put on the market in the shortest possible time. China Academy of Traditional Chinese Medicine Experimental Pharmaceutical Factory will also improve the prescription, production process, packaging, product image, strengthen advertising and other methods of old products such as pig ling polysaccharide injection, rest injury music tincture and other redevelopment, in order to enter the second growth, to extend the market life of the old products.